Trials / Completed
CompletedNCT00314821
Ropinirole in the Treatment of Bipolar Depression
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Cambridge Health Alliance · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate efficacy and safety of Requip in in treating bipolar depression.
Detailed description
This study is 8 weeks long, with an optional additional 8 weeks. The study is placebo-controlled and patients are randomized to receive either ropinerol or placebo. Changes in depression, anxiety and overall psychiatric symptoms will be monitored during participation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ropinirole |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2007-06-01
- Completion
- 2008-03-17
- First posted
- 2006-04-17
- Last updated
- 2017-04-18
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00314821. Inclusion in this directory is not an endorsement.